Tesla is unable to restart Shanghai production on Monday

Tesla is unable to restart Shanghai production on Monday


A truck transports new Tesla cars at its factory in Shanghai, China May 13, 2021.

Aly Song | Reuters

Tesla has notified workers and suppliers that production at its Shanghai factory will not resume on Monday as it had hoped, according to an internal notice shared with Reuters.

Reuters reported earlier on Sunday that the U.S. automaker aimed to resume production on Monday, citing two sources, as it expected to see its first batch of workers released from a lockdown the city imposed to combat a surge in Covid-19 cases.

However, Monday production plans have now been canceled, according to the notice, which did not elaborate on the reasons or say when the company expected activity to resume.

Production at Tesla’s Shanghai factory, which produces cars for the China market and is also a crucial export hub, has been halted since March 28 after the government launched a two-stage lockdown that started in areas east of the city’s Huangpu River where the plant is located.

Tesla had originally hoped to only halt operations for four days, but cancelled production plans for Friday and Saturday after the authorities extended tight movement restrictions in the eastern half of the city. Virtually all of Shanghai is currently under lockdown.

The current stoppage marks one of the longest suspensions since the factory started production in late 2019. Tesla manufactures 6,000 Model 3 and 10,000 Model Y cars per week at its Shanghai factory, one of the sources said.

Tesla did not immediately respond to requests for comment.

“This was an *exceptionally* difficult quarter due to supply chain interruptions and China zero-COVID policy,” its Chief Executive Officer Elon Musk said in a tweet on Saturday.

Subscribe to CNBC on YouTube.



Source

Doximity buys Pathway Medical for  million to help doctors get AI-powered answers
World

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021. Source: NYSE Doximity is diving deeper into artificial intelligence, announcing on Thursday the acquisition of startup Pathway Medical for $63 million.  Pathway has built an AI-powered clinical reference tool that doctors can use to ask questions about guidelines, drugs […]

Read More
Buy the dip on this ‘pure play automation’ stock, says Bank of America
World

Buy the dip on this ‘pure play automation’ stock, says Bank of America

Bank of America is sticking by Emerson Electric after a postearnings sell-off, as the company could benefit from manufacturing shifting back to the U.S. Emerson Electric’s fiscal third-quarter results were mixed, hurt by weaker-than-expected sales. The company, which makes autonomous technology and industrial goods, lowered its full-year outlook and now estimates sales will rise 3.5% […]

Read More
Switzerland will pursue further talks with US over crippling tariffs
World

Switzerland will pursue further talks with US over crippling tariffs

President of the Swiss Confederation, Karin Keller-Sutter (R) and Swiss Economy Minister Guy Parmelin depart at the Department of State after a meeting with US Secretary of State Marco Rubio, in Washington, DC on August 6, 2025. Drew Angerer | Afp | Getty Images Switzerland will continue talks with the United States, its president said […]

Read More